Drug Trial Radar · NCT00456521
A Safety and Efficacy Study of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects Participating in an Intensive Behavior Modification Program
Last checked: Nov 19, 2026Latest source record: Dec 17, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
793
Actual
Start
Mar 2007
Primary completion
Dec 2008
Study completion Dec 2008
Sponsor
- Lead sponsor
- Orexigen Therapeutics, IncIndustry
- Sponsor type
- Industry
- First posted
- Apr 5, 2007
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether a combination of naltrexone SR and bupropion SR is safe and effective in treating obesity and leads to greater weight loss when given with a group lifestyle modification program than with group lifestyle modification alone.
Conditions
- Obesity
- Overweight
Interventions
Naltrexone SR 32 mg/ bupropion SR 360 mg/ dayDrug
PlaceboDrug
Intensive group lifestyle modification counselingBehavioral
Primary outcomes
What the sponsor says the trial is designed to measure.
- Co-primary: Body Weight- Mean Percent ChangeTime frame: Baseline, 56 weeks
- Co-primary: Body Weight- Proportion of Subjects With ≥5% DecreaseTime frame: Baseline, 56 weeks
Locations
9 sites in 1 country. Site status is shown where the registry gives one.
University of California, San Diego: Dept of Family & Preventive Medicine
La Jolla, California
Center for Human Nutrition, University of Colorado Health Services Center
Denver, Colorado
Univ. of Florida, College of Public Health, and Health Professions
Gainesville, Florida
Washington Univ. Center for Human Nutrition
St Louis, Missouri
New York Obesity Research Center, St. Luke's-Roosevelt Hospital Center
New York, New York
Center for Weight and Eating Disorders, School of Med., University of Penn.
Philadelphia, Pennsylvania
Center for Obesity Research and Education, Temple University
Philadelphia, Pennsylvania
Medical University of S. Carolina Weight Management Center
Charleston, South Carolina
Behavioral Medicine Research Center
Houston, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.